Skip to main content
. 2018 Aug 2;51(5):e12480. doi: 10.1111/cpr.12480

Figure 3.

Figure 3

ZLDI‐8 sensitized colorectal cancer cells to 5‐FU and irinotecan. Cells were pre‐incubated with 0.78, 1.56 and 3.13 (μM) ZLDI‐8 for 1 h and then treated with different concentrations of 5‐FU (A) or irinotecan (B) in LoVo and SW480 cells for another 24 h, 48 h or 72 h. Cell proliferation was assessed by colony formation assay. ZLDI‐8 combined with 5‐FU (2 μM) (C) or irinotecan (8 μM) (D) in LoVo and SW480 cells. (E and F) Bar graphs showed the quantitative results of clonogenicity viability. *P < .05. **P < .01, ***P < .001 vs control. Irinotecan (irino)